Ryan Specialty [RYAN] vs Axis Capital [AXS] Detailed Stock Comparison
Ryan Specialty
NYSE
Loading...
Axis Capital
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Ryan Specialty wins in 4 metrics, Axis Capital wins in 15 metrics, with 0 ties. Axis Capital appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ryan Specialty | Axis Capital | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 147.55 | 8.99 | Axis Capital |
| Price-to-Book Ratio | 12.30 | 1.30 | Axis Capital |
| Debt-to-Equity Ratio | 309.01 | 24.11 | Axis Capital |
| PEG Ratio | 18.69 | 8.12 | Axis Capital |
| EV/EBITDA | 15.05 | 6.70 | Axis Capital |
| Profit Margin (TTM) | 2.02% | 14.30% | Axis Capital |
| Operating Margin (TTM) | 23.84% | 23.99% | Axis Capital |
| EBITDA Margin (TTM) | 23.84% | 23.99% | Axis Capital |
| Return on Equity | 16.98% | 15.07% | Ryan Specialty |
| Return on Assets (TTM) | 3.48% | 2.28% | Ryan Specialty |
| Free Cash Flow (TTM) | $467.87M | $1.84B | Axis Capital |
| Dividend Yield | 0.51% | 1.73% | Axis Capital |
| 1-Year Return | -7.73% | 25.91% | Axis Capital |
| Price-to-Sales Ratio (TTM) | 5.66 | 1.17 | Axis Capital |
| Enterprise Value | $11.60B | $8.47B | Ryan Specialty |
| EV/Revenue Ratio | 4.21 | 1.36 | Axis Capital |
| Revenue per Share (TTM) | $22 | $76 | Axis Capital |
| Earnings per Share (Diluted) | $0.40 | $10.40 | Axis Capital |
| Beta (Stock Volatility) | 0.64 | 0.82 | Ryan Specialty |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ryan Specialty vs Axis Capital Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ryan Specialty | 0.93% | -0.59% | -9.30% | -15.83% | -14.66% | -5.48% |
| Axis Capital | 1.13% | -0.55% | 0.36% | -6.22% | 5.41% | 8.53% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ryan Specialty | -7.73% | 36.41% | 107.07% | 107.07% | 107.07% | 107.07% |
| Axis Capital | 25.91% | 79.41% | 99.40% | 74.70% | 208.34% | 221.93% |
Performance & Financial Health Analysis: Ryan Specialty vs Axis Capital
| Metric | RYAN | AXS |
|---|---|---|
| Market Information | ||
| Market Cap | $15.58B | $7.31B |
| Market Cap Category | Large cap | Mid cap |
| 10 Day Avg. Volume | 1,335,130 | 755,050 |
| 90 Day Avg. Volume | 1,361,953 | 748,883 |
| Last Close | $59.75 | $97.54 |
| 52 Week Range | $55.77 - $77.16 | $74.27 - $107.19 |
| % from 52W High | -22.56% | -9.00% |
| All-Time High | $77.16 (Mar 31, 2025) | $107.19 (Jun 06, 2025) |
| % from All-Time High | -22.56% | -9.00% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.24% | 0.13% |
| Quarterly Earnings Growth | 0.11% | 0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.14% |
| Operating Margin (TTM) | 0.24% | 0.24% |
| Return on Equity (TTM) | 0.17% | 0.15% |
| Debt to Equity (MRQ) | 309.01 | 24.11 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $4.80 | $71.95 |
| Cash per Share (MRQ) | $1.40 | $11.56 |
| Operating Cash Flow (TTM) | $571.34M | $-402,564,992 |
| Levered Free Cash Flow (TTM) | $429.36M | $-690,687,360 |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.51% | 1.73% |
| Last 12-Month Dividend | $0.34 | $1.76 |
Valuation & Enterprise Metrics Analysis: Ryan Specialty vs Axis Capital
| Metric | RYAN | AXS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 147.55 | 8.99 |
| Forward P/E | 26.71 | 8.12 |
| PEG Ratio | 18.69 | 8.12 |
| Price to Sales (TTM) | 5.66 | 1.17 |
| Price to Book (MRQ) | 12.30 | 1.30 |
| Market Capitalization | ||
| Market Capitalization | $15.58B | $7.31B |
| Enterprise Value | $11.60B | $8.47B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.21 | 1.36 |
| Enterprise to EBITDA | 15.05 | 6.70 |
| Risk & Other Metrics | ||
| Beta | 0.64 | 0.82 |
| Book Value per Share (MRQ) | $4.80 | $71.95 |
Financial Statements Comparison: Ryan Specialty vs Axis Capital
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | RYAN | AXS |
|---|---|---|
| Revenue/Sales | $690.17M | $1.47B |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $51.04M | $236.10M |
| Income Tax | $55.43M | $44.32M |
| Net Income (Profit) | $-4.39M | $194.07M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | RYAN | AXS |
|---|---|---|
| Cash & Equivalents | $203.55M | $2.76B |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | $3.81B | $1.49B |
| Total Shareholders Equity | $1.06B | $5.90B |
| Retained Earnings | $79.34M | $7.49B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | RYAN | AXS |
|---|---|---|
| Operating Cash Flow | $-197.82M | $-284.52M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $-159.56M | $309.08M |
| Debt Repayment | $-154.25M | N/A |
| Common Stock Repurchase | N/A | $-439.99M |
Short Interest & Institutional Ownership Analysis
| Metric | RYAN | AXS |
|---|---|---|
| Shares Short | 4.93M | 1.98M |
| Short Ratio | 4.28 | 2.54 |
| Short % of Float | 0.04% | 0.03% |
| Average Daily Volume (10 Day) | 1,335,130 | 755,050 |
| Average Daily Volume (90 Day) | 1,361,953 | 748,883 |
| Shares Outstanding | 125.41M | 82.98M |
| Float Shares | 108.25M | 77.52M |
| % Held by Insiders | 0.14% | 0.01% |
| % Held by Institutions | 0.90% | 1.02% |
Dividend Analysis & Yield Comparison: Ryan Specialty vs Axis Capital
| Metric | RYAN | AXS |
|---|---|---|
| Last 12-Month Dividend | $0.34 | $1.76 |
| Last 12-Month Dividend Yield | 0.51% | 1.73% |
| 3-Year Avg Annual Dividend | $0.19 | $1.61 |
| 3-Year Avg Dividend Yield | 0.18% | 0.70% |
| 3-Year Total Dividends | $0.56 | $4.82 |
| Ex-Dividend Date | Mar 04, 2025 | Mar 31, 2025 |